Related Experiment Video
Updated: Apr 7, 2026
06:04
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
712
Rivaroxaban-associated Delayed Spontaneous Periprosthetic Hematoma
Kyra L Sierakowski1, Nicola R Dean1
1Department of Plastic and Reconstructive Surgery, Flinders Medical Centre, Bedford Park, South Australia, Australia; and Department of Surgery, Flinders University, Bedford Park, Adelaide, South Australia, Australia.
Plastic and Reconstructive Surgery. Global Open
|July 17, 2015
Summary
A delayed periprosthetic breast hematoma occurred spontaneously in a woman using Rivaroxaban. This case highlights a potential complication associated with anticoagulant therapy in breast reconstruction patients.
Area of Science:
- Plastic Surgery
- Cardiology
- Pharmacology
Background:
- Periprosthetic hematomas are a known complication following breast augmentation.
- Delayed onset hematomas are less common but can occur.
- Anticoagulant medications, such as Rivaroxaban, are frequently prescribed for various cardiovascular conditions.
Observation:
- A case study details a spontaneous, delayed periprosthetic breast hematoma.
- The patient was undergoing treatment with Rivaroxaban for an unspecified indication.
- The hematoma developed without apparent trauma or recent surgical intervention.
Findings:
- The spontaneous delayed periprosthetic breast hematoma is a rare but significant complication.
- Rivaroxaban use may be associated with an increased risk of delayed hematoma formation in breast implant patients.
- This presentation underscores the importance of considering anticoagulant effects in the etiology of delayed periprosthetic complications.
Implications:
- Clinicians should maintain a high index of suspicion for delayed hematomas in patients with breast implants, especially those on anticoagulants.
- Careful consideration of anticoagulant use and its potential risks is crucial in the perioperative and long-term management of breast augmentation patients.
- Further research may be warranted to elucidate the precise relationship between Rivaroxaban and delayed periprosthetic breast hematomas.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
466
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
01:30Venous Thrombosis IV: Nursing Management
388
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
388
01:23Peripheral Artery Disease V: Postoperative Nursing Management
587
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
587
01:30Venous Thrombosis I: Introduction
702
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
702
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.8K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.8K
01:24Disorders of Hemostasis
2.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K